Clinical Trial Update: Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bortezomib plus dexamethasone for acquired pure red cell aplasia after failure or relapse of first-line treatment. The study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Pure Red Cell Aplasia

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acquired Pure Red Cell Aplasia | Phase 2 | Status: COMPLETED